Harvest One Cannabis Stock (TSXV: HVT) (OTC: HRVOF) - Investor Dashboard


➔ Harvest One Cannabis
TSX Venture Exchange: HVT
OTC Ticker: HRVOF
Sector: Healthcare
Industry: Legal Cannabis
Country: Canada
Employees:  26
Established: 2015
CEO: Grant Froese

Summary

Fiscal Year-End: June
Facilities: 2
Dried Flower: Production and Sale
Extracts:   none
Number of Patients: na
Headquarters: Vancouver, BC

Financials (06/30/18)

Cash on hand: $56.8 million
Fixed Investment: $10.5  million
Shareholders’ Equity: $104.9  million
Revenues – Last Quarter: $514K
Adj. Gross Margin : -193.3%
EPS : -$0.03

Capital Structure (10/26/18)

Last Financing:  22.11 million Units at $1.82
Basic Shares: 173.8 million
Warrants: 33.7mm
Options: 15.4mm
Diluted Shares 222.9mm

Company Brief

Harvest One is a global cannabis company that develops and provides innovative lifestyle and wellness products to consumers and patients in regulated markets around the world. The Company’s range of lifestyle solutions is designed to enhance quality of life. Shareholders have significant exposure to the entire cannabis value chain through three wholly-owned subsidiaries: United Greeneries (a licensed producer), Satipharm (medical and nutraceutical), and Dream Water Global (consumer). For more information, please visit www.harvestone.com. The company has facilities in Lucky Lake, Saskatchewan and Duncan, British Columbia. Satipharm, which is generating revenue, focuses on oral delivery technologies. It has been producing Gelpell ® Microgel Capsules, a pharmaceutical grade product with GMP production, since May 2015. The company is focused on growth and distribution in the EU and Australia. Satipharm plans to export Gelpell ® Microgel products into the Canadian ACMPR market.

Featured Video

The United Greeneries’ flagship facility on Vancouver Island in Canada.


Harvest One completes acquisition of Dream Water and Dream Water Canada

The transaction will deliver a ready-made consumer goods marketing, distribution and product development division to Harvest One.  Dream Water is a natural, 2.5oz, 0-calorie, liquid sleep shot. Along with its sleep powder, Dream Water helps promote relaxation and support restful sleep. Dream Water is sold online and in over 30,000 North American retail outlets, while currently generating approximately $6 million per annum in revenue from its current product lines.

Dream Water has been embraced by a wide variety of celebrities including Kate Perry, Demi Moore, Paris Hilton, Kendall Jenner and more. It has also been featured in many mainstream media outlets. Dream Water was voted Canada’s Product of the Year for the Wellness Innovation category in 2017 and was awarded ‘Best in Show’ by Chatelaine.


HVST shareholders will have significant exposure to some of the largest commercial opportunities in the global cannabis sector

United Greeneries is a Canadian ACMPR Licensed Producer and will be HVST’s horticultural arm and recreational brand.

  • ACMPR (MMPR) Licensed Producer Duncan Facility in BC
  • Current capacity of ~1,000 kg/year, modular construction underway to triple capacity
  • Lucky Lake Facility in SK targets 8,500 kg/year
  • Outdoor grow in BC targets 50,000 kg/year with regulatory changes
  • Supply agreement with Ontario, British Columbia, Manitoba, and Saskatchewan

Satipharm is specialized in the development and manufacturing of cannabis- based health products and will be the company’s medical and health brand

  • Flagship Gelpell ® Microgel Capsules to lead growth
    • Near-term growth from supplement sales in EU
    • Mid-term growth from entry into regulated markets (Canada, Australia, etc.)
    • Significant growth opportunities globally
  • Global exclusive rights to Gelpell ® on cannabis applications; Gelpell Phase 1
  • Growing portfolio of delivery technology IP
  • Phase 1 and Phase 2 clinical trials complete

Focused on recreational and medical markets
HVST will be a well-financed, growth- oriented cannabis company focused on supplying Canadian and international medical and recreational cannabis markets.

United Greeneries
Canadian ACMPR Licensed Producer with focus on large-scale horticultural operations for the upcoming Canadian recreational cannabis market

Satipharm
International medical cannabis brand with focus on oral delivery technologies for strategic entry in emerging medical cannabis markets and the existing medical cannabis market in Canada

Dreamwater
All natural sleep aid currently selling in over 30,000 stores in North America

Burb
Retail cannabis company with plans to open eight to 10 stores in British Columbia by mid-2019 and plans to expand into Alberta, Saskatchewan, and Ontario


Highlights

  • Recreational and medical focus
  • Three brands
    • United Greeneries focused on large-scale production
    • Satipharm focused on oral delivery technologies
    • Dream Water and Dream Water Canada focused on the sleep aid market
  • Serving Canada and international markets, including Europe, Australia, and Israel
  • Strong balance sheet
  • Royal High premium cannabis brand and Captain’s Choice brand

Growth Strategy

  • In the final stages of the Lucky Lake Facility ACMPR application process
  • With regulatory changes, use 398 acres in BC for outdoor grow
  • 20,000 kilograms of cultivation capacity by the end of 2019
  • Expand Satipharm distribution in the EU, Australia, and preparing to import into Canada
  • Enter the global sleep and cannabis markets through Dream Water
  • New retail vertical with initial investment in Burb

Differentiators

  • Two indoor production facilities in two provinces
  • Wholesale rather than investing in competitive medical distribution in Canada
  • In-house QA/QC laboratory
  • Technology-driven portfolio of health products
  • Active in European CBD markets and engaged in clinical trials
  • Site selected for potential outdoor grow
  • United Greeneries: supply agreement with Manitoba Liquor and Lotteries and registered supplier with Saskatchewan Liquor and Gaming Authority
  • 20% investment in retail cannabis company Burb

Institutional Analyst Coverage

NEAL GILMER
Haywood Securities

GREG MCLEISH, CFA
Mackie Research


Curated Stories & News


Visit Harvest One Cannabis, Inc.
at www.harvestone.com.

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. Harvest One Cannabis, Inc., is a client of NCV Media, LLC. Read our full disclaimer.